Familial Risk of Dementia Associated With a Biologic Subtype of Alzheimer's Disease

Archives of General Psychiatry

Volumn 45, Issue 10, 1988, Pages 889-893

  Zubenko, George S ^a,c   Huff, F Jacob ^a,b   Beyer, Julia ^a   Teply, Ivana ^a   Auerbach, Jonathan ^d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c CARNEGIE MELLON UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALZHEIMER DISEASE; DEMENTIA; FAMILY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THROMBOCYTE MEMBRANE;

ACTUARIAL ANALYSIS; AGE FACTORS; AGED; ALZHEIMER DISEASE; BLOOD PLATELETS; CELL MEMBRANE; DIPHENYLHEXATRIENE; FEMALE; HUMAN; MALE; MEMBRANE FLUIDITY; MIDDLE AGE; MODELS, GENETIC; PHENOTYPE; RISK FACTORS; SPECTROMETRY, FLUORESCENCE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023755575     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1988.01800340011001     Document Type: Article

References (44)

1. Blass JP, Zemcov A: Alzheimer's disease: A metabolic systems degeneration? Neurochem Pathol 1984;2:103-114.
2. Hollander E, Mohs RC, Davis KL: Antemortem marker for Alzheimer's disease. Neurobiol Aging 1986;7:367-387.
3. Zubenko GS, Cohen BM, Growdon J, Corkin S: Cell membrane abnormality in Alzheimer's disease. Lancet 1984;2:235.
4. Zubenko GS, Cohen BM: Biophysical alterations in cell membranes associated with psychotherapeutic drug exposure, psychopathology, and aging. Psychopharm Bull 1985;21:631-640.
5. Zubenko GS, Cohen BM, Boller F, Reynolds CF, Malinakova I, Keefe N, Chojnacki B: Platelet membrane abnormality in Alzheimer's disease. Ann Neurol 1987;22:237-244.
6. Zubenko GS, Cohen BM, Reynolds CF, Boller F, Malinakova I, Keefe N: Platelet membrane fluidity in Alzheimer's disease and major depression. Am J Psychiatry 1987;144:860-868.
7. Zubenko GS, Malinakova I: Temperature dependence of the molecular dynamics of platelet membranes in Alzheimer's disease. Biol Psychiatry 1987;22:987-994.
8. Hicks N, Brammer MJ, Hymas N, Levy R: Platelet membrane properties in Alzheimer and multi-infarct dementias. J Alzheimer's Discord Assoc Disord 1987;1:90-97.
9. Pettegrew JW, Minshew NJ, Cohen MM, Kopp SJ, Glonek T: P-31 NMR changes in Alzheimer's and Huntington's disease brain, abstracted. Neurology 1984;34:281.
10. Barany M, Chang Y, Arus C, Rustan T, Frey WH: Increased glycerol3-phosphorylcholine in post-mortem Alzheimer's brain. Lancet 1985;1:517.
11. Chia LS, Thompson JE, Moscarello MA: X-ray diffraction evidence for myelin disorder in brain from humans with Alzheimer's disease. Biochim Biophys Acta 1984;775:308-312.
12. Zubenko GS: Hippocampal membrane alteration in Alzheimer's disease. Brain Res 1986;385:115-121.
13. Cohen BM, Zubenko GS, Babb S: Abnormal platelet membrane composition in Alzheimer's disease. Life Sci 1987;40:2445-2451.
14. Zubenko GS, Malinakova I, Chojnacki B: Proliferation of internal membranes in platelets from patients with Alzheimer's disease. J Neuropathol Exp Neurol 1987;46:407-418.
15. Zubenko GS, Cohen BM: Effects of phenothiazine treatment on the biophysical properties of platelet membranes from psychiatric patients. Biol Psychiatry 1985;20:384-396.
16. Zubenko GS, Teply I: Longitudinal study of platelet membrane fluidity in Alzheimer's disease. Biol Psychiatry, in press.
17. Larrson T, Sjogren T, Jacobson G: A clinical, sociomedical and genetic study. Acta Psychiatr Scand 1963;39(suppl 167):1-259.
18. Heston LL, Mastri AR, Anderson VE, White J: Dementia of the Alzheimer type: Clinical genetics, natural history and associated conditions. Arch Gen Psychiatry 1981;38:1085-1090.
19. Heyman A, Wilkinson WE, Hurwitz BJ, Schmechel D, Sigmon AH, Weinberg T, Helms MJ, Swift M: Alzheimer's disease: Genetic aspects and associated clinical disorders. Ann Neurol 1983;14:507-515.
20. Breitner JCS, Folstein MF: Familial Alzheimer's dementia: A prevalent disorder with specific clinical features. Psychol Med 1984;14:63-80.
21. Breitner JCS, Folstein MF, Murphy EA: Familial aggregation in Alzheimer dementia: I. A model for age-dependent autosomal dominant inheritance. J Psychiatr Res 1986;20:31-43.
22. Silverman JM, Breitner JCS, Mohs RC, Davis KL: The reliability of the family history method in Alzheimer's disease and related dementias. Am J Psychiatry 1986;143:1279-1282.
23. Mohs RC, Breitner JCS, Silverman JM, Davis KL: Alzheimer's disease: Morbid risk among first-degree relatives approximates 50% by 90 years of age. Arch Gen Psychiatry 1987;44:405-408.
24. Zubenko GS, Wusylko M, Boller F, Cohen BM, Teply I: Family study of platelet membrane fluidity in Alzheimer's disease. Science 1987;238:539-542.
25. McKhann G, Drachman D, Folstein MF, Katzman R, Price D, Stadlan E: Clinical diagnosis of Alzheimer's disease: Report of the NINCDSADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
26. Bird T, Stranahan S, Sumi SM, Raskind M: Alzheimer's disease: Choline acetyltransferase activity in brain tissue from clinical and pathological subgroups. Ann Neurol 1983;14:284-293.
27. Fuld PA, Katzman R, Davies P, Terry RD: Intrusions as a sign of Alzheimer's dementia: Chemical and pathological verification. Ann Neurol 1982;11:155-159.
28. Zubenko GS, Cohen BM: Effects of psychotropic agents on the physical properties of platelet membranes in vitro. Psychopharmacology 1985;86:369-373.
29. Zubenko GS, Cohen BM: A cell membrane correlate of tardive dyskinesia in patients treated with phenothiazines. Psychopharmacology 1986;88:230-236.
30. Folstein MF, Folstein SE, McHugh PR: ‘Mini-Mental State’: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
31. Corash L, Tan H, Gralnick HR: Heterogeneity of human whole blood platelet subpopulations: I. Relationship between buoyant density, cell volume, and ultrastructure. Blood 1977;49:71-87.
32. Heyn MP: Determination of lipid order parameters and rotational correlation times from fluorescence depolarization experiments. FEBS Lett 1979;108:359-364.
33. Jahnig F: Structural order of lipids and proteins in membranes: Evaluation of fluorescence anisotropy data. Proc Natl Acad Sci USA 1977;76:6361-6365.
34. Van Blitterswijk WJ, Van Hoeven RP, Van der Meer BW: Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements. Biochim Biophys Acta 1981;644:323-332.
35. Pottell H, Van der Meer BW, Herreman W: Correlation between the order parameter and the steady-state fluorescence anisotropy of 1,6-diphenyl 1,3,5-hexatriene and an evaluation of membrane fluidity. Biochim Biophys Acta 1983;730:181-186.
36. Huff FJ, Auerbach J, Chakravarti A, Boller F: Risk of dementia in relatives of patients with Alzheimer's disease. Neurology, in press.
37. Cutler SJ, Ederer F: Maximum utilization of the lifetable method in analyzing survival. J Chronic Dis 1958;8:699-713.
38. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Statist Assoc 1958;53:457-481.
39. Akesson HO: A population study of senile and arteriosclerotic psychoses. Hum Hered 1969;19:546-565.
40. Whalley LJ, Carothers AD, Collyer S, DeMay R, Frankiewicz AS: A study of familial factors in Alzheimer's disease. Br J Psychiatry 1982;140:249-256.
41. Heyman A, Wilkinson WE, Stafford JA, Helms MJ, Sigmon AH, Weinberg T: Alzheimer's disease: A study of epidemiologic aspects. Ann Neurol 1984;15:335-341.
42. French LR, Schuman LM, Mortimer JA, Hutton JT, Boatman RA, Christians B: A case control study of dementia of the Alzheimer's type. Am J Epidemiology 1985;121:414-421.
43. Amaducci LA, Fratigloni L, Rocca WA, Fieschi C, Livrea P, Pedone D, Bracco L, Lippa A, Gandolfo C, Bino G, Prencipe M, Bonatti ML, Girotti F, Carella F, Tavolta B, Ferla S, Lenzi GL, Carolei A, Gambi A, Grigoletto F, Schoenberg BS: Risk factors for clinically diagnosed Alzheimer's disease: A case control study of an Italian population. Neurology 1986;36:922-931.
44. St George-Hyslop PH, Tanzi RE, Polinaky RJ, Haines JL, Nee L, Watkins PC, Myers RH, Feldman RG, Pollen D, Drachman D, Growdon J, Bruni A, Foncin J, Salmon D, Frommelt P, Amaducci L, Sorbi S, Placentini S, Stewart GD, Hobbs WJ, Conneally M, Gusella JF: The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 1987;235:885-890.